RBC
HIMS icon

Roble Belko & Company’s Hims & Hers Health HIMS Stock Holding History

Roble Belko & Company’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
40
– – ﹤0.01% 422
2026
Q1 		$1K Hold
40
– – ﹤0.01% 422
2025
Q4 		$1K Hold
40
– – ﹤0.01% 429
2025
Q3 		$2K Hold
40
– – ﹤0.01% 357
2025
Q2 		$2K Buy
+40
New +$1.81K ﹤0.01% 337

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Roble Belko & Company's HIMS Position: Q2 2026 in Review

Roble Belko & Company held its Hims & Hers Health (HIMS) position steady in Q2 2026 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Roble Belko & Company first reported a position in HIMS in Q2 2025 and has held it in 5 quarters since. The position peaked at $2K in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Roble Belko & Company held 40 shares of Hims & Hers Health worth $1K as of Q2 2026.
  • Roble Belko & Company left its Hims & Hers Health share count unchanged in Q2 2026.
  • Hims & Hers Health made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #422 holding.
  • Roble Belko & Company first reported a position in Hims & Hers Health in Q2 2025 and has held it in 5 quarters since.
  • Roble Belko & Company's Hims & Hers Health position peaked at $2K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.